Emerging Cerebrospinal Fluid Biomarkers of Disease Activity and Progression in Multiple Sclerosis

Дата публикации: 01-04-2024 00:00:00

This cohort study examines data from 2 prospective multiple sclerosis cohorts to identify cerebrospinal fluid measures associated with relapsing and nonrelapsing progressive multiple sclerosis pathobiology.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Serum GFAP Dynamics, Disease Progression, and Therapy Response in MS	0	8.04	03-08-2026
2	Teriflunomide and Time to Clinical Multiple Sclerosis in Radiologically Isolated Syndrome	0	6.92	01-10-2023
3	These fat-filled brain cells may be making multiple sclerosis worse	0	7.88	29-06-2026
4	Tau Oligomer–Containing Synapses Engulfed by Microglia and Astrocytes in Alzheimer Disease	0	7.6	01-11-2023
5	White Matter Hyperintensities in Alzheimer Disease	0	6.14	01-12-2023
6	Blood Biomarkers to Detect Alzheimer Disease in Primary and Secondary Care	0	5.63	15-10-2024
7	Prognostic Value of Blood-Based P-Tau217 Levels for Progression to Cognitive Impairment	0	14.88	14-07-2026
8	p-Tau 217 and Aβ42/40 to Predict Early Brain Aβ Accumulation	0	15.37	01-09-2024
9	Clinical Correlates of Cognitive Impairment in Progressive Supranuclear Palsy and Multiple System Atrophy: A Comparative Neuropsychological Study	0	5	15-07-2026
10	White Matter Hyperintensity Burden Is Associated With Altered Functional Network Topology and Enhanced Structural-Functional Coupling in Cerebral Small Vessel Disease	0	7	14-07-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 8.77. Источник: archderm.jamanetwork.com.